A Study of Dulaglutide in Chinese Participants

NCT01667900 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Healthy Volunteers

Interventions

DRUG: Dulaglutide
DRUG: Placebo

Sponsor

Eli Lilly and Company